Stay updated with breaking news from Nasdaq Adma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) shares reached a new 52-week high on Monday . The stock traded as high as $5.35 and last traded at $5.33, with a volume of 2526018 shares traded. The stock had previously closed at $5.09. Analyst Upgrades and Downgrades A number of analysts have commented on ADMA […]
Assenagon Asset Management S.A. reduced its stake in ADMA Biologics, Inc. (NASDAQ:ADMA – Free Report) by 10.7% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,034,171 shares of the biotechnology company’s stock after selling 605,799 shares during the period. Assenagon Asset […]
ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report)’s share price reached a new 52-week high during mid-day trading on Monday after Mizuho raised their price target on the stock from $7.00 to $9.00. Mizuho currently has a buy rating on the stock. ADMA Biologics traded as high as $5.30 and last traded at $5.24, with […]
ADMA Biologics (NASDAQ:ADMA – Free Report) had its target price boosted by HC Wainwright from $5.00 to $6.00 in a report published on Tuesday morning, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for ADMA Biologics’ Q4 2023 earnings at $0.03 EPS, Q1 2024 earnings […]
ADMA Biologics (NASDAQ:ADMA – Free Report) had its target price boosted by HC Wainwright from $5.00 to $6.00 in a report published on Tuesday morning, Benzinga reports. They currently have a buy rating on the biotechnology company’s stock. HC Wainwright also issued estimates for ADMA Biologics’ Q4 2023 earnings at $0.03 EPS, Q1 2024 earnings […]